A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

NCT03339219 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda